Scientific Director, Medical Payer Strategy - Oncology

The Scientific Director provides medical and scientific input into medical market access payer, group purchasing organizations, health systems, guidelines, and pathways oncology scientific objectives and tactics for healthcare access decision makers. Develops and executes medical market access activities such as payer/healthcare access decision maker strategies, educational initiatives (medical education, data, guidelines, pathways, and value proposition), and translates payer/HCMD insights into . Works cross functionally in a highly matrixed environment with commercial, HEOR and medical affairs teams to provide strategic payer/HCDM input into brand strategies and shape integrated holistic value evidence plan .
Leads development of medical affairs payer/HCDM strategy for the assigned therapeutic area and assets, translating the clinical, economic, humanistic, and real-world evidence into a differentiated value narrative that shapes access strategy, brand and portfolio priorities, and enterprise decisions.
Actively participates in relevant cross functional brand, medical affairs and market access teams to provide medical, scientific, pharmaeconomic, and healthcare landscape input into portfolio and product strategies, influences without authority in a matrixed environment.
Leads development and approval of medical affairs access/HCDM field and omnichannel materials.
Leads and delivers training to the Medical Outcomes Science Liaison teams
Partners on the development of integrated evidence plan with Medical Affairs, HEOR to support scientific and business strategy aligned to Medical Affairs Evidence Gaps;
Develops strategy for payer/HCDM collaborative customer research, thought-leadership forums, and external partnerships aligned with therapeutic area and AbbVie objectives in partnership with HEOR and medical affairs.
Monitors scientific, health economic, access and healthcare policy trends through conferences, insights gathering and external engagement; proactively provide and provide proactive inputs into portfolio, therapeutic area and brand strategies.
Responsible for compliance with applicable Corporate and Divisional Policies and procedures. Responsible for understanding the legal and regulatory requirements as well as the healthcare landscape and accountable for complying with those requirements. Serves as the scientific team interface for key regulatory, OEC and Legal discussions.
May assist with the scientific review, development, execution and communication of medical affairs sponsored or supported RWE research activities.
Lead cross functional and functional sub teams responsible for discrete projects within the therapeutic area.
Advanced Education PhD, PharmD, PA, NP highly preferred. Residency or additional post doctorate highly preferred.
Typically 8 years’ experience in the pharmaceutical industry or equivalent; substantial understanding of managed care required and pharmacoeconomic experience preferred.
Management and leadership experience at project level, experience with strategic initiatives and issues. Proven leadership skills in a cross-functional environment. International experience is a plus.
Ability to interact externally and internally to support global business strategy. Ability to advance RWE studies or medical affairs directed research independently with little supervision. Knowledge of statistical methodology, regulatory requirements governing RWE and experience in development strategy and the design of RWE protocols.
Must possess excellent oral and written communication skills.
Works mostly independently with limited guidance.
.Hybrid position based in one of our locations.

Employment type
Full-time

Work arrangement
Hybrid